Retinoid X Receptor Selective Agonists and their Synthetic Methods

Area of Science:

• Molecular Biology
• Endocrinology
• Pharmacology

Background:

• Retinoid X Receptor (RXR), a nuclear receptor superfamily member identified in 1990, is expressed in all human cells.
• RXR isoforms (α, β, γ) are vital for physiological regulation, partnering with other nuclear receptors.
• RXR forms permissive heterodimers (e.g., with PPAR, LXR) and nonpermissive heterodimers (e.g., with VDR, TR, RAR), influencing nutrient metabolism and gene expression.

Purpose of the Study:

• To review synthetic methodologies for potent rexinoids.
• To highlight the significance of rexinoids in regulating gene expression and cellular processes.
• To provide an overview of small molecule rexinoid development over the past 25 years.

Main Methods:

• Literature review of synthetic methods for rexinoids.
• Analysis of reported potent rexinoid compounds.
• Summary of chemical synthesis strategies.

Main Results:

• Several potent rexinoids have been synthesized and reported.
• Synthetic methods vary, enabling diverse rexinoid structures.
• Rexinoids can activate RXR homodimers to regulate gene expression, inhibit proliferation, and induce apoptosis.

Conclusions:

• RXR plays a central role in nuclear receptor-mediated signaling.
• Small molecule rexinoids offer therapeutic potential, particularly in oncology.
• Continued research into synthetic methods is crucial for developing effective rexinoid-based treatments.